Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.

Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits

Open access

Abstract

The accumulation of extracellular β-amyloid (Aβ) plaques within the brain is unique to Alzheimer’s disease (AD) and thought to induce synaptic deficits and neuronal loss. Optimal therapies should tackle the core AD pathophysiology and prevent the decline in memory and cognitive functions. This study aimed to evaluate the therapeutic performance of mesenchymal stem cell-derived exosomes (MSC-exosomes), which are secreted membranous elements encapsulating a variety of MSC factors, on AD. A human neural cell culture model with familial AD (FAD) mutations was established and co-cultured with purified MSC-exosomes. 2-[18F]Fluoro-2-deoxy-d-glucose ([18F]FDG) and novel object recognition (NOR) testing were performed before/after treatment to evaluate the therapeutic effect in vivo. The AD-related pathology and the expression of neuronal memory/synaptic plasticity-related genes were also evaluated. The results showed that MSC-exosomes reduced Aβ expression and restored the expression of neuronal memory/synaptic plasticity-related genes in the cell model. [18F]FDG-PET imaging and cognitive assessment revealed a significant improvement in brain glucose metabolism and cognitive function in AD transgenic mice. The phase of neurons and astrocytes in the brain of AD mice were also found to be regulated after treatment with MSC-exosomes. Our study demonstrates the therapeutic mechanism of MSC-exosomes and provides an alternative therapeutic strategy based on cell-free MSC-exosomes for the treatment of AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines9060594

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Characterization of MSC-exosomes. (A) TEM analysis of purified MSC-exosomes. The arrow indicates MSC-exosomes; scale bar: 50 nm. Size distribution of exosomes as measured by nanoparticle tracking analysis (NTA) showed a peak at 155 nm. (B) Western blot analysis of the proteins in MSC-exosomes (Exo) and MSCs (cell). (C) The slices were imaged under 40×, 63×, and 100× objectives after DAPI counterstaining, using a confocal microscope with laser sources of 594 nm. The white-dashed square represents a field-of-view corresponding to the image with higher magnification. Arrows indicate PKH26-labeled MSC-exosomes. Scale bars, 50 μm (top), 20 μm (middle), and 10 μm (bottom). Abbreviation: TEM, transmission electron microscopy; MSC, mesenchymal stem cell; HSP 70, heat shock protein 70.
Figure 1 Characterization of MSC-exosomes. (A) TEM analysis of purified MSC-exosomes. The arrow indicates MSC-exosomes; scale bar: 50 nm. Size distribution of exosomes as measured by nanoparticle tracking analysis (NTA) showed a peak at 155 nm. (B) Western blot analysis of the proteins in MSC-exosomes (Exo) and MSCs (cell). (C) The slices were imaged under 40×, 63×, and 100× objectives after DAPI counterstaining, using a confocal microscope with laser sources of 594 nm. The white-dashed square represents a field-of-view corresponding to the image with higher magnification. Arrows indicate PKH26-labeled MSC-exosomes. Scale bars, 50 μm (top), 20 μm (middle), and 10 μm (bottom). Abbreviation: TEM, transmission electron microscopy; MSC, mesenchymal stem cell; HSP 70, heat shock protein 70.CC BY · PubMed Central
Figure 2 MSC-exosomes decrease the level of Aβ and prevent the downregulation of memory/synaptic plasticity-related genes. (A) Representative images of Aβ expression in the FAD cell culture model after one-week treatment and quantitative data of the average Aβ expression. Red: Aβ; Blue: DAPI; BF, bright field. Scale bar, 20 μm. Right graph depicts the quantification of five random areas in arbitrary units. Data are mean ± SEM. (* p < 0.05, ** p < 0.01, *** p < 0.001 by Tukey’s post hoc test, n.s., nonsignificant) (B) Quantitative RT-PCR results of plasticity-related genes. Data are expressed as mean ± SEM.
Figure 2 MSC-exosomes decrease the level of Aβ and prevent the downregulation of memory/synaptic plasticity-related genes. (A) Representative images of Aβ expression in the FAD cell culture model after one-week treatment and quantitative data of the average Aβ expression. Red: Aβ; Blue: DAPI; BF, bright field. Scale bar, 20 μm. Right graph depicts the quantification of five random areas in arbitrary units. Data are mean ± SEM. (* p < 0.05, ** p < 0.01, *** p < 0.001 by Tukey’s post hoc test, n.s., nonsignificant) (B) Quantitative RT-PCR results of plasticity-related genes. Data are expressed as mean ± SEM.CC BY · PubMed Central
Figure 3 MSC-exosomes enhance [18F]FDG uptake in the whole brain and in different brain regions. (A) Representative [18F]FDG PET imaging of an AD transgenic mouse and a WT mouse (n = 6–8/each group). Sagittal (right) and coronal (left) slices were projected on a built-in T1 MRI mouse template (scale by kBq/c.c). Right graph: quantification of whole brain in SUV. Data are expressed as mean ± SEM; n.s., Nonsignificant. (* p < 0.05, ** p < 0.01, *** p < 0.001 by Tukey’s post hoc test) (B) [18F]FDG uptake in different brain regions in Tg and wild-type (WT) mice. SUV means standardized uptake value. Abbreviation: CTX, cortex; TH, thalamus; BFS, basal forebrain; STR, striatum; HP, hippocampus; AMY, amygdala.
Figure 3 MSC-exosomes enhance [18F]FDG uptake in the whole brain and in different brain regions. (A) Representative [18F]FDG PET imaging of an AD transgenic mouse and a WT mouse (n = 6–8/each group). Sagittal (right) and coronal (left) slices were projected on a built-in T1 MRI mouse template (scale by kBq/c.c). Right graph: quantification of whole brain in SUV. Data are expressed as mean ± SEM; n.s., Nonsignificant. (* p < 0.05, ** p < 0.01, *** p < 0.001 by Tukey’s post hoc test) (B) [18F]FDG uptake in different brain regions in Tg and wild-type (WT) mice. SUV means standardized uptake value. Abbreviation: CTX, cortex; TH, thalamus; BFS, basal forebrain; STR, striatum; HP, hippocampus; AMY, amygdala.CC BY · PubMed Central
Figure 4 MSC-exosomes improve cognitive function. (A) After MSC-exosomes treatment, the NOR test was used to assess the long-term recognition memory in all groups (10 months of age). Histograms are mean ± SEM of the corresponding DI (Discrimination index). One-way ANOVA revealed a significant effect of treatment (F = 5.93, p = 0.0046. * p < 0.05, ** p < 0.01 by Tukey’s post hoc test). (B) The NOR test was performed before and after MSC-exosomes treatment. Two-way ANOVA was used, and a significant interaction was found between the factors Tg × treatment (p = 0.0049 by Bonferroni post hoc test).
Figure 4 MSC-exosomes improve cognitive function. (A) After MSC-exosomes treatment, the NOR test was used to assess the long-term recognition memory in all groups (10 months of age). Histograms are mean ± SEM of the corresponding DI (Discrimination index). One-way ANOVA revealed a significant effect of treatment (F = 5.93, p = 0.0046. * p < 0.05, ** p < 0.01 by Tukey’s post hoc test). (B) The NOR test was performed before and after MSC-exosomes treatment. Two-way ANOVA was used, and a significant interaction was found between the factors Tg × treatment (p = 0.0049 by Bonferroni post hoc test).CC BY · PubMed Central
Figure 5 MSC-exosomes reduce Aβ plaque burden, inhibit astrocyte activation, and upregulate memory- and synapse-related genes. (A) Transgenic or WT mice were treated with MSC-exosomes or PBS for 4 weeks, and at the end of treatment, homogenized brain tissues were analyzed by SDS-PAGE and immunoblotting. Representative Western blot of soluble Aβ immunoprobed using Aβ antibody and visualized by ECL is shown. Internal control: β-actin. (B) Quantitative RT-PCR results of plasticity-related genes from extracted hemispheres. Data are mean ± SEM (* p < 0.05 and *** p < 0.001 by Student’s t-test). (C) Representative confocal micrographs of sagittal brain sections, immunolabeled with GFAP, in the hippocampus. Red, GFAP; Blue: DAPI. Scale bar, 100 μm (top), 50 μm (bottom). Quantification of GFAP+ cells within a region of interest (Area = 0.05 mm2). Data are mean ± SEM (p = 0.0043. ** p < 0.01 by Student’s t-test).
Figure 5 MSC-exosomes reduce Aβ plaque burden, inhibit astrocyte activation, and upregulate memory- and synapse-related genes. (A) Transgenic or WT mice were treated with MSC-exosomes or PBS for 4 weeks, and at the end of treatment, homogenized brain tissues were analyzed by SDS-PAGE and immunoblotting. Representative Western blot of soluble Aβ immunoprobed using Aβ antibody and visualized by ECL is shown. Internal control: β-actin. (B) Quantitative RT-PCR results of plasticity-related genes from extracted hemispheres. Data are mean ± SEM (* p < 0.05 and *** p < 0.001 by Student’s t-test). (C) Representative confocal micrographs of sagittal brain sections, immunolabeled with GFAP, in the hippocampus. Red, GFAP; Blue: DAPI. Scale bar, 100 μm (top), 50 μm (bottom). Quantification of GFAP+ cells within a region of interest (Area = 0.05 mm2). Data are mean ± SEM (p = 0.0043. ** p < 0.01 by Student’s t-test).CC BY · PubMed Central
Figure 6 MSC-exosomes downregulate HDAC4 expression and restore the levels of target genes. (A) Representative confocal micrographs of a FAD cell culture immunolabeled with HDAC4. In total, 50 μg of MSC-exosomes was administered to differentiated cells twice a week. Red, HDAC4; Green: amyloid-β; Blue: DAPI. Quantification of HDAC4 labeling intensity in FAD-differentiated cells. Data are mean ± SEM (*** p < 0.001; n.s., nonsignificant by Student’s t-test). (B) Representative confocal micrographs of sagittal brain sections immunolabeled with HDAC4 in the cortex. Red, HDAC4; Blue: DAPI. Quantification of HDAC4+ cells within a region of interest (Area = 0.05 mm2). Data are mean ± SEM. The slices were imaged under 20×, 40× and 100× objectives after DAPI staining. Scale bars, 100 μm (top), 50 μm (middle) and 20 μm (bottom). (C) Quantitative RT-PCR results for HDAC4 target genes. Data are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 and n.s., nonsignificant by Student’s t-test.
Figure 6 MSC-exosomes downregulate HDAC4 expression and restore the levels of target genes. (A) Representative confocal micrographs of a FAD cell culture immunolabeled with HDAC4. In total, 50 μg of MSC-exosomes was administered to differentiated cells twice a week. Red, HDAC4; Green: amyloid-β; Blue: DAPI. Quantification of HDAC4 labeling intensity in FAD-differentiated cells. Data are mean ± SEM (*** p < 0.001; n.s., nonsignificant by Student’s t-test). (B) Representative confocal micrographs of sagittal brain sections immunolabeled with HDAC4 in the cortex. Red, HDAC4; Blue: DAPI. Quantification of HDAC4+ cells within a region of interest (Area = 0.05 mm2). Data are mean ± SEM. The slices were imaged under 20×, 40× and 100× objectives after DAPI staining. Scale bars, 100 μm (top), 50 μm (middle) and 20 μm (bottom). (C) Quantitative RT-PCR results for HDAC4 target genes. Data are expressed as mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001 and n.s., nonsignificant by Student’s t-test.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 67 references

Cited by

See all 180

Metadata

Authors
Chen, Y.-A., Lu, C.-H., Ke, C.-C., Chiu, S.-J., Jeng, F.-S., Chang, C.-W., Yang, B.-H., & Liu, R.-S.
Affiliations
  • National Yang Ming Chiao Tung University (TW)
  • Kaohsiung Medical University (TW)
  • Taiwan Mouse Clinic (TW)
  • Taipei Veterans General Hospital (TW)
Corresponding author
  • Ke, Chien-Chih
  • Liu, Ren-Shyan
Venue
Biomedicines
Publisher
MDPI AG
Published
2021-05-24
Volume
9
Issue
6
Pages
594
ISSN
2227-9059 (ISSN-L)
OpenAlex
W3165350824
Cited by
167
References
67
Citations by year
2026: 28 · 2025: 38 · 2024: 49 · 2023: 25 · 2022: 20 · 2021: 7
FWCI
15.87
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Science and Technology (MOST-107-2321-B-075-001, MOST 108-2319-B-001-003)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
mesenchymal stem cell-derived exosomes, Alzheimer's disease, amyloid plaques, familial Alzheimer's disease, cognitive impairment, synaptic plasticity, brain glucose metabolism, cell-free therapy, astrocytes, transgenic mouse model, novel object recognition

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits. https://app.cochat.ai/papers/10.3390/biomedicines9060594
The paper
Chen, Y.-A., Lu, C.-H., Ke, C.-C., Chiu, S.-J., Jeng, F.-S., Chang, C.-W., Yang, B.-H., & Liu, R.-S. (2021). Mesenchymal Stem Cell-Derived Exosomes Ameliorate Alzheimer’s Disease Pathology and Improve Cognitive Deficits. Biomedicines. https://doi.org/10.3390/biomedicines9060594

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.